AxoGen (AXGN)
(Delayed Data from NSDQ)
$14.08 USD
-0.59 (-4.02%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $14.09 +0.01 (0.07%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Income Statements
Fiscal Year end for AxoGen, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 159 | 139 | 127 | 112 | 107 |
Cost Of Goods | 31 | 24 | 23 | 22 | 17 |
Gross Profit | 128 | 114 | 104 | 91 | 89 |
Selling & Adminstrative & Depr. & Amort Expenses | 149 | 144 | 130 | 114 | 121 |
Income After Depreciation & Amortization | -21 | -30 | -25 | -23 | -31 |
Non-Operating Income | 3 | 1 | 0 | 0 | 2 |
Interest Expense | 3 | 1 | 1 | 1 | 0 |
Pretax Income | -22 | -29 | -27 | -24 | -29 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -22 | -29 | -27 | -24 | -29 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -22 | -29 | -27 | -24 | -29 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -15 | -24 | -20 | -20 | -29 |
Depreciation & Amortization (Cash Flow) | 6 | 6 | 6 | 4 | 3 |
Income After Depreciation & Amortization | -21 | -30 | -25 | -23 | -31 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 42.88 | 42.08 | 41.22 | 39.97 | 39.24 |
Diluted EPS Before Non-Recurring Items | -0.51 | -0.67 | -0.59 | -0.60 | -0.68 |
Diluted Net EPS (GAAP) | -0.51 | -0.69 | -0.65 | -0.60 | -0.74 |
Fiscal Year end for AxoGen, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 47.91 | 41.38 | 42.92 | 41.27 | 38.16 |
Cost Of Goods | 12.57 | 8.76 | 9.16 | 8.04 | 7.23 |
Gross Profit | 35.35 | 32.62 | 33.76 | 33.23 | 30.93 |
SG&A, R&D, and Dept/Amort Expenses | 35.78 | 37.18 | 36.96 | 37.25 | 37.83 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.43 | -4.56 | -3.20 | -4.02 | -6.90 |
Non-Operating Income | 0.69 | 0.25 | 1.15 | 0.76 | 0.39 |
Interest Expense | 2.19 | 2.33 | 1.84 | 0.83 | 0.15 |
Pretax Income | -1.92 | -6.64 | -3.89 | -4.09 | -6.66 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.92 | -6.64 | -3.89 | -4.09 | -6.66 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.92 | -6.64 | -3.89 | -4.09 | -6.66 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 43.71 | 43.23 | 43.05 | 43.02 | 42.86 |
Diluted EPS Before Non-Recurring Items | -0.04 | -0.15 | -0.09 | -0.10 | -0.16 |
Diluted Net EPS (GAAP) | -0.04 | -0.15 | -0.08 | -0.10 | -0.16 |